Advising Elevator Fund on the valuation of BiomX, a clinical stage therapeutics firm.

Flow Partners performed a confidential valuation of BiomX, a clinical stage microbiome therapeutics company.

Tel Aviv, Israel
·27 January 2021

Overview

Elevator Fund required an actionable valuation advice for BiomX in order to accurately balance and keep pulse on their venture portfolio.

We have provided an independent valuation opinion that included development pipeline analysis, risk-adjusted NPV (rNPV), comparable environment analysis, portfolio impact, operational benchmarking, green/red flag analysis and more.

This transaction highlights our strong track record in digital health and biotech space, having also advised and valued companies like AVE & YOU (personalized skincare) or Code Pharma (pharmaceuticals).

About BiomX

BiomX (NYSE and TASE: PHGE) is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.

About Elevator Fund

Elevator Fund invests in exceptional early-stage startups globally. Elevator leads and syndicates seed rounds, investing between $250K-$1M in innovative companies located in Israel, Europe and the US. Elevator invests in areas of fintech, new media, digital health and other emerging fields.

About Flow Partners

Flow Partners provides founder-friendly corporate finance and fractional CFO advice to technology entrepreneurs globally. Flow was founded in 2020 and operates globally with presence in London, Berlin, Warsaw and Miami.

For more information, please visit flowpartners.io.

Enquires

For all enquiries please contact the team at hi@flowpartners.io

More clients we've worked with

Fractional CFO

Stages

Countries

Cities

Sectors

© 2026 Flow Partners (London) Ltd. All rights reserved. Registered as a limited liability company in England and Wales (registered number 12969521).

Advising Elevator Fund on the valuation of BiomX, a clinical stage therapeutics firm. | Flow Partners